Daten des Robert Koch-Instituts: 7-Tage-Inzidenz & Hospitalisierungen & GrippeWeb-Wochenbericht & AMELAG
Das aktuelle Corona-Krankheitsaufkommen in Deutschland beträgt schätzungsweise 110 Fälle pro 100.000 Einwohner, was bedeutet, dass ca. eine von 636 Personen derzeit akut infiziert ist (angenommen sind Ø 10 Tage Infektionsdauer). Das Robert-Koch-Institut (RKI) meldet eine auf meldepflichtigen PCR-Tests basierte Inzidenz von 0, wobei auf jede offiziell registrierte Infektion etwa 357 weitere unentdeckte Fälle entfallen. Informationen zur aktuellen Verteilung zirkulierender SARS-CoV-2-Varianten finden sich im RKI-Dashboard.
Die auf dem GrippeWeb-Wochenbericht basierte Inzidenz aller Atemwegserkrankungen beträgt 5.170 pro 100.000 Einwohner, was bedeutet, dass ca. eine von 19 Personen derzeit akut infiziert ist (angenommen sind Ø 7 Tage Infektionsdauer; Vergleich zu den Vorjahren). Stand: 15.09.2026
Der Risikorechner macht infektiöse Aerosol-Gefahren in Innenräumen sichtbar und unterstützt dabei, das tatsächliche Ansteckungsrisiko realistisch einzuschätzen.
Risiko berechnen
Rund um das Immunsystem gibt es viele Mythen und Missverständnisse. Dieser Text klärt einige häufige Fragen wissenschaftlich fundiert auf.
Weiterlesen
Four Years of Clinical Experience With COVID-19 Outcomes in Heart Transplant Recipients. 15.09.2026
The accessory protein ORF3a hijacks the CLCC1 chloride channel to disrupt ER homeostasis in betacoronavirus pathogenesis. 15.09.2026
Nitrile-Based Inhibitors Targeting both SARS-CoV‑2 Main Protease and Human Cathepsin L 15.09.2026
Integrated Genotypic and Phenotypic Surveillance Reveals the Evolutionary Dynamics of SARS-CoV-2 Variants During the First Four Years of the COVID-19 Pandemic 15.09.2026
Insights into the mechanism of action of the bipartite fusion module of SARS-CoV-2 spike protein 15.09.2026
Pilot Monitoring of SARS-CoV-2 RNA in Influent and Treated Effluent of Municipal Wastewater Treatment Plants Across Slovakia During the Autumn 2020 COVID-19 Wave 15.09.2026
SARS-CoV-2 spike-armed vesicular stomatitis virus recapitulates severe COVID-19 acute respiratory distress syndrome in mice 15.09.2026
Synthesis of Novel Pyrazolopyranopyrimidine Acyclic Nucleosides Disubstituted at N2/C5 as Potential Anti-SARS-CoV-2 Inhibitors:Structural Characterization, and In Silico Studies 15.09.2026
Potent halt of SARS-CoV-2 replication using clitocine-induced emergent-viral-RNA editing and disruption 15.09.2026
Comparative Evidence-Weighted In Silico Toxicity Profiling of the SARS-CoV-2 Main Protease Inhibitors Ensitrelvir and Nirmatrelvir 15.09.2026
Rhabdomyolysis Reported in Association with SARS-CoV-2 Infection and COVID-19 Vaccination:A Systematic Review 15.09.2026
Publisher Correction:Design, structure-based optimization and antiviral evaluation of potent inhibitors for the macrodomain Mac1 of SARS-CoV-2 15.09.2026
Correlation of SARS-CoV-2 RT-PCR cycle threshold with C-reactive protein and clinical outcomes in patients with COVID-19 pneumonitis:A retrospective observational study 15.09.2026
Marine phlorotannins block SARS-CoV-2 entry via ACE2 and attenuate pulmonary inflammation in K18-hACE2 transgenic mice 15.09.2026
Systematic screening of Citri reticulatae pericarpium polysaccharides reveals uronic acid–associated anti-SARS-CoV-2 activity 15.09.2026
BỆNH LÝ TIM MẠCH SAU NHIỄM CORONA VIRUS (SARS-COV-2) 15.09.2026
Antibody evasion and receptor binding of SARS-CoV-2 RW.1.1 15.09.2026
Remdesivir Maintains Antiviral Potency Against Clinically Relevant SARS-CoV-2 Nsp12 Substitutions. 14.09.2026
Phase 2 Evaluation of two GEO-CM04S1 Dose Levels Shows Comparable Safety and Broad Immunogenicity. 14.09.2026
Bidirectional Associations Between Autonomic Function, Sleep Quality, and Daily Fatigue and Energy Symptoms in Long COVID:Longitudinal Digital Health Study. 14.09.2026
[Mobilization of Long Covid patients:from lived experience to the co-construction of research and care pathways]. 14.09.2026
A 35-Year-Old Woman Presenting With Life-Threatening Fulminant Myocarditis After COVID-19:A Case Report. 14.09.2026
Correction:Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization. 14.09.2026
Short and Long time Impact of SARS-CoV-2 on clinical characters of Graves' Disease Patients:A Retrospective Cohort Study. 14.09.2026
Disulfide bonds stabilize the SARS-CoV-2 RBD and preserve binding to ACE2 following thermal denaturation. 14.09.2026
Longitudinal characterization of mixed-genotype SARS-CoV-2 infections in a military cohort reveals compartmentalized viral populations. 14.09.2026
Trace of the tracer:Techno-solutionism, surveillance and the ambivalent experiences of digital health in Türkiye's COVID-19 response. 14.09.2026
FRET-based nanoprobes for nucleic acid sensing and disease diagnosis:materials, probe architectures, and analytical trends. 14.09.2026
SEROPREVALENCE OF SARS-CoV-2 SERUM IgG ANTIBODY IN ADULT POPULATION OF SIALKOT CITY, PAKISTAN:A CROSS- SECTIONAL STUDY 14.09.2026
From Endemic Baseline To Summer Peak:Six-Month Multiplex PCR Surveillance Of SARS-Cov-2 Resurgence And Displacement Of Respiratory Pathogens In Eastern China, March–August 2026 14.09.2026
Correction:Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization 14.09.2026
Beyond seropositivity:SARS-CoV-2 IgG responses in high-risk COVID-19 patients 14.09.2026
Remdesivir Maintains Antiviral Potency Against Clinically Relevant SARS-CoV-2 Nsp12 Substitutions 14.09.2026
Short and Long time Impact of SARS-CoV-2 on clinical characters of Graves' Disease Patients:A Retrospective Cohort Study 14.09.2026
Disulfide bonds stabilize the SARS-CoV-2 RBD and preserve binding to ACE2 following thermal denaturation 14.09.2026
Molecular Etiology and Mortality Risk Stratification of Non-SARS-CoV-2 Severe Acute Respiratory Infection in a Predominantly Pediatric Cohort:A Retrospective Study From a Tertiary Care Hospital in North India 14.09.2026
Longitudinal characterization of mixed-genotype SARS-CoV-2 infections in a military cohort reveals compartmentalized viral populations 14.09.2026
Evaluation of the Antiviral Activity of Cuscuta Extracts Against HSV-1, HSV-2 (ACV-Resistant Strain), HCoV229E and SARS-CoV-2 14.09.2026
Targeted ORF8-N Sanger Sequencing as a SARS-CoV-2 Surveillance Contingency During Supply Shortages 14.09.2026
Immune cell interactions and lung damage in SARS-CoV-2 special attention on monocytes/macrophages, T and B lymphocytes, dendritic cells and Toll-like receptors in SARS-CoV-2 14.09.2026
Measuring Anti-Spike IgG Antibody Response to SARS-COV-2 Vaccination in Patients Receiving Hemodialysis at a Tertiary Care Hospital of Lahore 14.09.2026
PREVALENCE OF SARS-COV-2 IN ASYMPTOMATIC END STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS & DIALYSIS PROVIDERS DURING SARS-COV-19 SPIKE IN LAHORE 14.09.2026
Computational Identification of Shikimic Acid Derivatives as Potential SARS-CoV-2 Inhibitors:An In Silico Approach 14.09.2026
3D Electron Diffraction Elucidates the Structure of a 1,3,5-Triazin-2,4-dione Cinnamamide Covalent Inhibitor of SARS-CoV-2 3CLpro 14.09.2026
Dynamic γδ T-cell Receptor remodeling and antigen-induced T-cell IFN-γ responses after SARS-CoV-2 infection during pregnancy:insights for γδ T-cell immunotherapy 14.09.2026
Antigenic remodeling of the SARS-CoV-2 Spike N-terminal domain links sequence variability to structural reorganization of a neutralizing antibody supersite 14.09.2026
ACE2 Polymorphisms rs2285666 and rs147311723 Are Clinically Relevant Variants in SARS-CoV-2 and Mycobacterium tuberculosis Co-infection. 13.09.2026
GENOMIC SURVEILLANCE AND TRANSMISSION DYNAMICS OF SARS-COV-2:A MATHEMATICAL AND COMPUTATIONAL APPROACH TO PANDEMIC RESPONSE 12.09.2026
Glassy Carbon Electrode-Integrated Microfluidic CD Platform for Point-of-Care Detection of SARS-CoV-2 Spike Protein and Prostate-Specific Antigen 12.09.2026
‘Performance of an antigen test for detection of SARS-CoV-2, influenza and respiratory syncytial virus’ – Author’s reply 12.09.2026
Comparison of S2 Subunits of the Spike (S) Glycoprotein From Different Strains of SARS-Cov-2 (COVID-19), Aiming to Understand the S2 Role in Virus Transfection Which May Help Its Harness 12.09.2026
A Case of SARS-COV-2 Infection Complicated by DIC Syndrome in a Patient with Idiopathic Pulmonary Hemosiderosis 12.09.2026
Glycans located upstream of the furin cleavage site in SARS-CoV-2 Spike protein influence its processing and functions 12.09.2026
Longitudinal antibody correlates of SARS-CoV-2 infection in a US household cohort during Omicron waves 12.09.2026
Circulating cholesterol fuels SARS-CoV-2 replication via ORF3a. 11.09.2026
Synergistic effect of combinational SHEN26 and PF07817883 in SARS-CoV-2 infection. 11.09.2026
Healthy vaccinee effect in SARS-CoV-2 vaccinees without documented infection 11.09.2026
SARS-CoV-2 Coinfections and Severity in Hospitalized Children With Systematic Testing. 10.09.2026
Exploring novel isatin derivatives as SARS-CoV-2 3CL<sup>pro</sup> inhibitors. 10.09.2026
Computational Identification of Shikimic Acid Derivatives as Potential SARS-CoV-2 Inhibitors:An In Silico Approach. 08.09.2026
Antagonism of stress granules is key to SARS-CoV-2 infection and pathogenesis. 08.09.2026
COVID-19-Associated Fungal Co-Infections:Pathogenesis, Diagnostics, Biomarkers, and Therapeutic Strategies. 06.09.2026
A decade of evaluating burnout among American medical students using the OLBI-MS. 06.09.2026
Vitamin D and Health:Establishing Causal Relationships Through Observational Evidence and Hill's Criteria in a Biological Framework. 04.09.2026
New-onset diabetes following SARS-CoV-2 Omicron infection:a matched cohort study 04.09.2026
Let-7a-5p/SHIP-1 Axis Drives SARS-CoV-2 Spike-1-Induced Microglial Pyroptosis. 03.09.2026
Trop-1/EpCAM Thr115 is a driver of hyperproliferative cell repair and of severe lung damage in COVID-19. 03.09.2026
The Impact of Severe Albuminuria on the Proinflammatory Monocyte Subset CD14++CD16+ and Antigen-Specific Immune Responses. 02.09.2026
Crosstalk between SARS-CoV-2 and the angiotensin system:Clinical implications. 02.09.2026
The Pan-African Natural Products Library compounds oleanolic acid, poinsettifolin B, and rhuschalcone III disrupt SARS-CoV-2 Spike-host ACE2 interactions and SARS-CoV-2 replication 02.09.2026
Exploring the Pyrimidine Scaffold for the Development of SARS-CoV-2 Mpro Inhibitors. 01.09.2026
Myalgia:a wake-up call for SARS-CoV-2 infection in adolescents? 01.09.2026
The C117D oxidation mimic reveals the monomeric structure of SARS-CoV-2 main protease. 01.09.2026
Factors Associated with Transport Instability and Outcome Deterioration During Interhospital Intensive Care Transfers of Patients with COVID-19 in Germany. 31.08.2026
Heterogeneity of Immunological, Coagulation and Complement Clustering to Viral Challenge and Clinical Relevance. 31.08.2026
Switching Spike Plasticity Shapes ACE2 Engagement Across SARS-CoV-2 Variants. 31.08.2026
Immunity interrupted:Links between SARS-CoV-2 and the tripledemic of 2022. 30.08.2026
From HIV to SARS-CoV-2 associated neurological disorder ("HAND" to "SAND"):Viral infection as a "time-bomb" for the aging brain. 29.08.2026
Navigating Therapeutic Frontiers:A Meta-review and Meta-analysis of COVID-19 Treatment Options. 28.08.2026
Identification of Potential SARS-CoV-2 Main Protease (MPro) Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Approaches. 27.08.2026
COVID-19 and Suicide Mortality in a Population-Based Medico-Legal Registry:An Interrupted Time-Series and Changepoint Analysis from Southeast Romania. 26.08.2026
Associations and Multidimensional Characterization of the Nutritional-Inflammatory Profile in Children with Previous SARS-CoV-2 Infection:A Retrospective Cohort Study. 26.08.2026
A Selenium-Deficient Mouse Model of Mouse-Adapted SARS-CoV-2 Demonstrates Variant Emergence Observed in SARS-CoV-2 Pandemic Variants 26.08.2026
Severe Vision Impairment and Its Association with COVID-19 Susceptibility, Severity, and Mortality:A Population-Based Cohort Study. 25.08.2026
Cross-Virus RNA Language Models for Within-Family RNA-RNA Interaction Prediction in SARS-CoV-2 and Porcine Deltacoronavirus. 24.08.2026
Scarless SARS-CoV-2 Genome Engineering and Variant Analysis 24.08.2026
Vitamin D and COVID-19:Inmunomodulatory Effects and the Mexican Public Health Perspectives. 22.08.2026
Antibody-mediated SARS-CoV-2 entry and conformational regulation. 21.08.2026
Antiviral activity of nirmatrelvir against contemporary SARS-CoV-2 variants. 17.08.2026
The effects of SARS-CoV-2 on bone homeostasis. 03.08.2026
Convalescent plasma for persistent symptomatic COVID-19 infection in immune-suppressed patients - a case series. 01.08.2026
Advances on Sensors and Diagnostics of SARS-CoV-2 Biomarkers. 01.08.2026
Exploration of Nirmatrelvir Derivatives as Optimized SARS-CoV-2 Antivirals. 01.08.2026
Impact of Gestational Maternal SARS-CoV-2 Infection on Neonatal Inflammatory Biomarkers. 01.08.2026
SARS-CoV-2 Neutralization Breadth Is Shaped by Variant Exposure and Immune History. 01.08.2026
Cobalt(III)-Schiff Base Coordination to Nsp1, a SARS-CoV-2 Protein. 01.08.2026
Discovery of human antibody specific to the spike glycoprotein subunit 2 of SARS-CoV-2 and characterization of its broad-spectrum neutralizing activity. 30.07.2026
Salivary polyreactive and SARS-CoV-2-specific antibody responses following SARS-CoV-2 infection and vaccination in healthcare workers. 28.07.2026
SARS-CoV-2 resistance pathways to EDP-235. 27.07.2026
Long-term SARS-CoV-2 Persistence in Syrian Hamsters 20.07.2026
Quellen: PubMed, Europe PMC & CrossRef
Fünf Jahre nach dem Tod meiner Mutter durch Covid-19. - Vietnam.vn 15.09.2026
Mainz: Brand bei Covid-Impfstoff-Hersteller Biontech - drei Menschen in Klinik - TAG24 15.09.2026
Eine besondere Kunstperformance für Kinder, die durch die Covid-19-Pandemie zu Waisen geworden sind. - Vietnam.vn 15.09.2026
Wir setzen unsere fünfjährige Reise der Unterstützung von Waisenkindern fort, die von der Covid-19-Pandemie betroffen sind. - Vietnam.vn 15.09.2026
Long COVID: Phase-2-Daten zu Bezisterim am 15. September - ad-hoc-news.de 15.09.2026
Studienfehlschlag bei Long COVID: BioVie Aktie bricht ein - Investing.com Deutsch 15.09.2026
ANZEIGE: Diese 5 Corona-Irrtümer halten sich hartnäckig - BILD 15.09.2026
Long-Covid-Kolumne: Der Sommer ist vorbei – Halleluja! - Apotheken Umschau 15.09.2026
Post-Covid-Therapie in Marburg: Versorgung am Limit - Oberhessische Presse 11.09.2026
Impfung gegen Corona und Grippe: Ist der richtige Zeitpunkt jetzt? - Gesundheit - SZ.de - SZ.de 11.09.2026
Oktoberfest: So gut schützen Impfungen vor Atemwegsinfekten - tagesschau.de 11.09.2026
Wen dürfen Apotheker auf Kassenkosten gegen COVID-19 impfen? - Deutsche Apotheker Zeitung, DAZ 11.09.2026
XFG-COVID-19-Impfstoff als Fertigspritze verfügbar - Deutsche Apotheker Zeitung, DAZ 10.09.2026
COVID-19 - Auswärtiges Amt 08.09.2026
Long-Covid oder ME/CFS - ein Fehler im Immunsystem? - ZDF 01.09.2026
COVID-19-Impfung: STIKO ändert ihre Empfehlungen - Apotheken Umschau 28.08.2026
Post-Covid-Syndrom: Blutwäsche zeigt in Studie keinen Nutzen für Betroffene - DGfN 17.06.2026
Homepage | Eckpunktepapier für die medizinische Rehabilitation bei Post-COVID-Syndrom - Deutsche Rentenversicherung 20.05.2026
Gesellschaftliche Kosten durch Long COVID und ME/CFS steigen weiter – 64,4 Milliarden Euro allein in 2025 - ME/CFS Research Foundation 27.04.2026
Myth-busters- debunking long COVID myths and misconceptions - World Health Organization (WHO) 03.02.2026
Quelle: Google News
Pluslife ist ein Molekulartest (PoC-NAT) für zuhause: besser als Antigen-Schnelltests bei niedriger Viruslast – und mit Analyzer-Webapp von »virus.sucks« werden Ergebnisse nachvollziehbar.
Safe Air Docs hilft dabei, Arztpraxen mit hohen Infektionsschutzstandards zu finden. So wird der Arztbesuch sicherer – besonders für Menschen mit erhöhtem Gesundheitsrisiko.
Am 15. und 16. Mai 2024 fand die virtuelle Konferenz #UniteToFight2024 statt und zog über 10.000 Teilnehmer an, die sich über die neuesten Entwicklungen zu Long Covid und ME/CFS informierten. Führende Experten wie Dr. David Putrino und Prof. Akiko Iwasaki präsentierten aktuelle Forschungsergebnisse.
Die Übertragung durch Aerosole ist einer der am schwierigsten zu vermeidenden Infektionswege, kann aber durch FFP2- und FFP3-Masken effektiv blockiert werden.
2023: Golda Schlaff und 15 weitere prominente Ärzt:innen fordern mehr Respekt vor den Patient:innen, die Wiedereinführung von FFP2-Masken bei steigenden Inzidenzen sowie den flächendeckenden Einsatz von HEPA-Filtern in medizinischen Einrichtungen.